文献速递糖尿病

血糖控制不佳与糖尿病患者医疗费用之间的关联:一项基于人群的研究

The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study.
PubMed 文献 · Diabetes Care · 2020-02-06

该研究从加泰罗尼亚卫生研究所电子数据库提取100,391例2型糖尿病患者的医疗资源利用数据,用多变量回归模型分析血糖控制(HbA1c)对总医疗费用、住院费用和药物费用的影响。结果显示血糖控制越差,总医疗费用、住院概率及药物费用越高。作者认为良好的血糖控制和预防策略可减轻该病的经济负担。

要点

  • 血糖控制越差,总医疗费用越高:与血糖控制良好相比,血糖控制极差和差者费用分别增加18%(€509.82)和23%(€661.35)。
  • 模型2中血糖控制差者住院概率比良好者高5%,且发生住院时平均费用更高(€811)。
  • 模型2中血糖控制一般者药物费用增加12%,血糖控制极差者增加28%。

核心结论

  • 血糖控制不佳与更高的总医疗费用、住院费用和药物费用直接相关。
  • 作者认为,在2型糖尿病患者中采取预防策略和良好的血糖控制可减轻该病相关的经济影响。

研究设计与样本

  • 研究从加泰罗尼亚卫生研究所使用的电子数据库中提取100,391例2型糖尿病患者的医疗资源利用数据。
  • 采用多变量回归模型检验血糖控制(HbA1c)对总医疗费用、住院费用和药物费用的影响;模型1校正多种协变量,模型2额外纳入微血管和大血管并发症。
  • 血糖控制分类:良好为HbA1c <7%,一般为≥7%至<8%,差为≥8%至<10%,极差为≥10%。

主要发现

  • 每例患者年均直接医疗费用为€3,039 ± SD €6,581。
  • 与血糖控制良好相比,血糖控制极差和差者总医疗费用分别增加18%(€509.82)和23%(€661.35)(未校正);模型2中分别增加€428.3和€395.1。
  • 模型2中,血糖控制一般者药物费用增加12%,血糖控制极差者增加28%。
  • 血糖控制差者住院概率比良好者高5%(模型2),且发生住院时平均费用更高(€811)。

关键数值与推荐

  • 血糖控制良好:HbA1c <7%;一般:≥7%至<8%;差:≥8%至<10%;极差:≥10%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the differences in health care costs according to glycemic control in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: Data on health care resource utilization from 100,391 people with type 2 diabetes were extracted from the electronic database used at the Catalan Health Institute. Multivariate regression models were carried out to test the impact of glycemic control (HbA1c) on total health care, hospital admission, and medication costs; model 1 adjusted for a variety of covariates, and model 2 also included micro- and macrovascular complications. Glycemic control was classified as good for HbA1c <7%, fair for ≥7% to <8%, poor for ≥8% to <10%, and very poor for ≥10%. RESULTS: Mean per patient annual direct medical costs were €3,039 ± SD €6,581. Worse glycemic control was associated with higher total health care costs: compared with good glycemic control, health care costs increased by 18% (€509.82) and 23% (€661.35) in patients with very poor and poor glycemic control, respectively, when unadjusted and by €428.3 and €395.1, respectively, in model 2. Medication costs increased by 12% in patients with fair control and by 28% in those with very poor control (model 2). Patients with poor control had a higher probability of hospitalization than those with good control (5% in model 2) and a greater average cost when hospitalization occurred (€811). CONCLUSIONS: Poor glycemic control was directly related to higher total health care, hospitalization, and medication costs. Preventive strategies and good glycemic control in people with type 2 diabetes could reduce the economic impact associated with this disease.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mata-Cases M, Rodríguez-Sánchez B, Mauricio D, et al. The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study. Diabetes Care. 2020. PMID: 32029636. doi:10.2337/dc19-0573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。